Related Experiment Video
Updated: Aug 29, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Molecular biology of prion diseases
1Institut für Molekularbiologie I, Universität Zürich, 8093 Zürich, Switzerland.
Abstract:
What is the nature of the transmissible agent responsible for neurodegenerative diseases such as scrapie and mad-cow disease in animals and Creutzfeldt-Jakob disease in man? There is now weighty evidence that PrP(Sc), a modified version of the ubiquitously expressed host protein PrP(C), is responsible for pathogenesis of these diseases and that conversion of PrP(C) into PrP(Sc) under the influence of PrP(Sc) is the process leading to the propagation of PrP(Sc) and disease progression.
Insights
The transmissible agent causing neurodegenerative diseases like Mad-Cow disease is PrP(Sc), a modified host protein. Its conversion from PrP(C) drives disease progression.
Area of Science:
- Neurobiology
- Prion Diseases
- Molecular Biology
Background:
- Neurodegenerative diseases such as scrapie, mad-cow disease, and Creutzfeldt-Jakob disease are linked to a transmissible agent.
- The host protein PrP(C) is ubiquitously expressed.
Purpose of the Study:
- To identify the nature of the transmissible agent responsible for prion diseases.
- To elucidate the mechanism of prion propagation and pathogenesis.
Main Methods:
- The study focuses on the role of PrP(Sc) in prion disease pathogenesis.
- It examines the conversion process of PrP(C) to PrP(Sc).
Main Results:
- Weighty evidence indicates that PrP(Sc), a modified form of PrP(C), is the pathogenic agent.
- The conversion of PrP(C) into PrP(Sc) is influenced by existing PrP(Sc).
Conclusions:
- PrP(Sc) is the key agent in the pathogenesis of prion diseases.
- The autocatalytic conversion of PrP(C) to PrP(Sc) explains disease propagation and progression.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents
Parkinson Disease ll: Pathophysiology
Rabies
Leaky Scanning

